Literature DB >> 15104680

Polymorphism of HLA-B27 in Taiwanese Chinese.

K L Yang1, I-H Chen, C K Hsiao, J M Cherng, K Z Yang, C C Chang, C C Yeh, P Y Lin.   

Abstract

Heterogeneity of HLA-B27 is represented by a family of 24 closely related alleles/subtypes. Frequency and disease association of these alleles with spondyloarthropathies differ among ethnic groups. Accurate investigation of frequencies of alleles is often hindered by the size and demographic region of sample tested. With an ever-increasing number of B27 alleles being discovered, it is becoming imperative to establish disease association of each individual alleles and its biological importance. In a large number of normal healthy Taiwanese Chinese individuals (75,777) tested nationally, over a period of five years, in a single immunogenetics centre, we found additional B27 subtypes not revealed in a previous Taiwanese Chinese population study. The subtypes found in Taiwanese Chinese and the frequencies of each of the subtypes are reported.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15104680     DOI: 10.1111/j.0001-2815.2004.00197.x

Source DB:  PubMed          Journal:  Tissue Antigens        ISSN: 0001-2815


  3 in total

1.  The association of HLA-B*27 subtypes with ankylosing spondylitis in Wuhan population of China.

Authors:  Xiang Liu; Li-Hua Hu; Yi-Rong Li; Feng-Hua Chen; Yong Ning; Qun-Feng Yao
Journal:  Rheumatol Int       Date:  2009-06-18       Impact factor: 2.631

2.  rs10865331 associated with susceptibility and disease severity of ankylosing spondylitis in a Taiwanese population.

Authors:  Ya-Feng Wen; James Cheng-Chung Wei; Yu-Wen Hsu; Hung-Yi Chiou; Henry Sung-Ching Wong; Ruey-Hong Wong; Shiro Ikegawa; Wei-Chiao Chang
Journal:  PLoS One       Date:  2014-09-03       Impact factor: 3.240

3.  Comparison of HLA-B*27 subtypes between Chinese patients with ankylosing spondylitis and non-ankylosing spondylitis carriers.

Authors:  Fangjun Luo; Zhigang Zhao; Jie Zhang; Jianhang Leng
Journal:  J Int Med Res       Date:  2019-06-10       Impact factor: 1.671

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.